Pharmaceuticals
- Feb- 2023 -3 FebruaryStock Market
Omicron subvariant that’s dominant in U.S. extends lead over other variants in latest week, CDC data shows – News Opener
The omicron subvariant that became dominant in the U.S. several weeks ago continued to extend its lead over other variants…
Read More » - 2 FebruaryUS News
Tracking the opioid crisis: Inside the DEA’s secret lab | CNN
Watch CNN Films’ “American Pain” at 9 p.m. ET Sunday, February 5. CNN — Sitting among the warehouses of Dulles,…
Read More » - 2 FebruaryStock Market
WHO counted nearly 20 million new COVID cases in latest month as it shifts from weekly reporting schedule – News Opener
The World Health Organization said nearly 20 million new COVID cases were recorded in the 28 days through Jan. 29,…
Read More » - 2 FebruaryStock Market
Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter – News Opener
Eli Lilly’s LLY, -5.11% new Type 2 diabetes treatment Mounjaro may be in high demand, but the drug had a…
Read More » - 2 FebruaryStock Market
This trader nailed two big market calls in 2022. She says investors are ‘being paid to wait’ so should steer clear of stocks for 2023. – News Opener
Ahead of major tech earnings, Meta results are ready to light up the Nasdaq Composite COMP, +2.00% for Thursday. The…
Read More » - 2 FebruaryStock Market
New Alzheimer’s drug shows some promise, but has big price tag – News Opener
The Food and Drug Administration recently granted fast-track approval to a new Alzheimer’s drug designed to slow the rate of…
Read More » - 1 FebruaryStock Market
GSK posts higher sales and profit of $1.85 billion, lifted by specialty medicines and vaccines businesses – News Opener
GSK PLC on Wednesday posted rising earnings and sales for the fourth quarter, which the company said were boosted by…
Read More » - Jan- 2023 -31 JanuaryStock Market
Darktrace stock falls after New York short seller takes stake – News Opener
Shares in cybersecurity firm Darktrace DARK, -8.09% fell as much as 7% in Tuesday London trading after short seller Quintessential…
Read More » - 31 JanuaryStock Market
This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run – News Opener
The S&P 500 SPX, -1.30% is about to wrap up its best month since November, up more than 4% in…
Read More » - 30 JanuaryStock Market
Cannabis industry’s spending on Washington lobbying hits record – News Opener
The cannabis industry set a record in its spending on Washington lobbying last year, with its outlay of $5.43 million.…
Read More »
